Analysis
Asia Society’s Cure4Cancer Initiative Proposes Solutions for Unlocking $80bn Oncology R&D Investment and Reducing Global Cancer Disparities
Sept 24, 2024
A study conducted by Bloomberg New Economy International Cancer Coalition, McKinsey Cancer Center, and Cure4Cancer in collaboration with Memorial Sloan Kettering Cancer Center revealed patient access and participation in oncology clinical trials remain fewer than 5% globally and suggest solutions to lower barriers to access in order to accelerate the ‘cure for cancer’.
Remote Monitoring and Data Collection for Decentralized Clinical Trials
April 12, 2024
Assessing the current global state of adoption of decentralized trial technologies, understanding factors that may be driving or preventing adoption, and highlighting aspirations and direction for industry to enable more patient-centric trials.
Continue Reading Remote Monitoring and Data Collection for Decentralized Clinical Trials
Moonshot Explainer
March 15, 2022
Cancer Moonshot has the potential to change thousands of lives. It has the potential to be a forum to address health inequality and an incubator for cutting-edge research; it could be a centerpiece of community engagement and a catalyst for American industrial renewal. The project could reignite an American “national purpose,” paving the way for the U.S. to one day work internationally on comprehensive cancer care.
Advancing Global Health Equity
November 1, 2023
Read a new report by the Asia Society Policy Institute’s Center for China Analysis and Cure4Cancer, Advancing Global Health Equity: Enhancing Clinical Trials Access and Cooperation to Save Millions of Lives from Cancer.
We Need a Global System for Testing and Approving Cancer Treatments
October 18, 2022
C4C Taskforce member Dr. Bob Li and colleagues explain how by establishing harmonized regulations for oncology therapies’ approvals globally, the number of annual cancer-related deaths could be reduced by 10% to 20%, saving 1 to 2 million lives.
Continue Reading We Need a Global System for Testing and Approving Cancer Treatments
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
April 19, 2022
The article discusses the establishment of the Bloomberg New Economy International Cancer Coalition, which aims to improve patient access to cancer clinical trials and harmonize regulations globally in the post-pandemic era.
